Clinical significance unveiled: Understanding the meaning of FACE-Q skin cancer scores for improved patient care Journal Article
| Authors: | Veldhuizen, I. J.; Dusza, S. W.; Kuo, A.; Aleisa, A.; Blue, E.; Adhikari, S.; Nadir, U.; Le, K.; Kazemi, S.; Sutton, A. V.; Nijhawan, R. I.; Eisen, D. B.; Rossi, A. M.; Srivastava, D.; Wysong, A.; Nehal, K. S.; Klassen, A. F.; Lee, E. H. |
| Article Title: | Clinical significance unveiled: Understanding the meaning of FACE-Q skin cancer scores for improved patient care |
| Abstract: | Objective: The FACE-Q Skin Cancer Module is a Patient-Reported Outcome Measure (PROM) utilized to assess outcomes following facial skin cancer resection. However, the lack of Minimal Important Difference (MID) estimates hinders the interpretability of the PROM scores. This study established MID estimates for the four outcome scales from the FACE-Q Skin Cancer Module using distribution-based methods. Methods: A prospective cohort study at four hospitals in the United States, enrolled participants who underwent Mohs Micrographic Surgery (MMS) for facial skin cancer between April 2020 and April 2022. Participants completed the Satisfaction with Facial Appearance, Appearance-related Psychosocial Distress, Cancer Worry, and Appraisal of Scars scales at four time points: pre-operatively, 2-week, 6-month, and 1-year post-surgery. Results: A total of 990 patients participated in the study, with completion rates of 98.4% for the pre-operative assessment, 70.8% at 2 weeks, 59.3% at 6 months, and 60.4% at 1 year. MID estimates, calculated using 0.2 standard deviation and 0.2 standardized response mean, were determined for the four scales. The mean MID estimates, based on a Rasch transformed score ranging from 0 to 100, were 5 for the Appraisal of Scars scale and 4 for the remaining three scales. Conclusion: This multicenter study provides valuable MID estimates for the FACE-Q Skin Cancer Module, specifically for the MMS patient population, enabling clinicians and researchers to better interpret scores, determine appropriate sample sizes, and apply the findings in clinical care. © 2024 John Wiley & Sons Ltd. |
| Keywords: | adult; aged; aged, 80 and over; middle aged; patient satisfaction; cancer surgery; major clinical study; clinical trial; squamous cell carcinoma; united states; outcome assessment; preoperative evaluation; prospective study; prospective studies; quality of life; basal cell carcinoma; skin neoplasms; facial neoplasms; skin cancer; cohort analysis; psychology; questionnaire; patient care; skin tumor; multicenter study; scoring system; distress syndrome; surgery; patient reported outcome measures; mohs surgery; mohs micrographic surgery; rasch analysis; scar; minimal important difference; cicatrix; face tumor; demographics; patient-reported outcome; clinical relevance; facies; clinical significance; very elderly; humans; human; male; female; article; patient worry; likert scale; surveys and questionnaires; face q skin cancer module |
| Journal Title: | Psycho-Oncology |
| Volume: | 33 |
| Issue: | 10 |
| ISSN: | 1057-9249 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2024-10-01 |
| Start Page: | e70009 |
| Language: | English |
| DOI: | 10.1002/pon.70009 |
| PUBMED: | 39420453 |
| PROVIDER: | scopus |
| PMCID: | PMC11789771 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding MSK author is Erica H. Lee -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work